Low-molecular-weight heparin during percutaneous coronary interventions: Rationale, results, and recommendations

Low-molecular-weight heparin vs. unfract

Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: A combined analysis

✍ Maria Borentain; Gilles Montalescot; Anissa Bouzamondo; Rémi Choussat; Jean-Séba 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract This meta‐analysis assessed the rates of the efficacy and safety endpoints with intravenous low‐molecular‐weight heparin (LMWH) compared with unfractionated heparin (UFH) in patients undergoing percutaneous coronary intervention (PCI). Subcutaneous LMWH has compared favorably with UFH,